A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma | Zendy

AI Assistant Blog Pricing

Open Access

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

Author(s) -

Li Wang,

Shao-Quan Zhou,

Yu Zhou,

Jia-xi Lu

Publication year - 2022

Publication title -

journal of immunology research

Language(s) - English

Resource type - Journals

eISSN - 2314-8861

pISSN - 2314-7156

DOI - 10.1155/2022/8069858

Subject(s) - immune system , adenocarcinoma , oncology , medicine , biology , cancer research , immunology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.